JAZZJazz PharmaceuticalsHealth Care
$218.42EarningsNov 4, 2026
1D—1W—1M—3M—1Y—
Market cap$15.2BCompany infoRevenue$4.6B52-wk range$129 – $262IndustryBiotechnologyWebsitejazzpharma.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +69.3% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E14.9×7588
14
1719
P / S3.3×4050
2
4
P / FCF9.8×8193
5
16
EV / EBITDA11.7×6281
7
96
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin84.7%9589
84%
90%
Operating margin31.1%8688
-12%
31%
Net margin20.4%7983
-14%
20%
ROE22.1%6977
-12%
22%
ROIC14.8%7268
-4%
15%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.913828
0.9
2.1
Net debt / EBITDA1.5×5051
Current ratio1.786446
Interest coverage7.3×5452
Per shareTTM, with year-over-year change
Revenue / share$66.30▲ +13%
EPS (diluted)$14.63▲ +317%
FCF / share$22.22▲ +22%
Est. EPS growth (fwd)—